SANA BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.72 USD | +2.59% |
|
+14.59% | +113.73% |
Chart calendar Sana Biotechnology, Inc.
61bf8127d5004cf8c41f4.9D94PYyhFCgBfmSqx8a6eokV_ht8K7COyH01vDUyelY.nlMXWMnmVXdrEyyTkYfKDvpXz0wOROLDqzVh83pgEj_DTi51zctNd0sNNQ~3d4d1ad8f6e5a078be3d35377791639b
Upcoming events on Sana Biotechnology, Inc.
Past events on Sana Biotechnology, Inc.
| 07/03/2024 01:20 am | TD Cowen Health Care Conference |
| 01/03/2024 02:35 am | Q4 2023 Earnings Release |
| 09/01/2024 11:15 pm | JPMorgan Healthcare Conference |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract Number:3630 |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract Number:3290 |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract Number:3437 |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract Number:3631 |
| 10/12/2023 07:00 am | American Society of Hematology Meeting - Abstract Number:2252 |
| 07/12/2023 12:30 am | JMP Securities Hematology and Oncology Summit |
| 29/11/2023 11:50 pm | Evercore ISI HealthCONx Conference |
| 09/11/2023 02:35 am | Q3 2023 Earnings Release |
| 27/09/2023 08:25 pm | Cantor Global Healthcare Conference |
| 12/09/2023 11:05 pm | Morgan Stanley Global Healthcare Conference |
| 11/09/2023 07:30 pm | H.C. Wainwright Global Investment Conference |
| 07/09/2023 11:45 pm | Wells Fargo Healthcare Conference |
| 06/09/2023 08:00 pm | Citi BioPharma Conference |
| 04/08/2023 01:35 am | Q2 2023 Earnings Release |
| 12/06/2023 10:30 pm | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 09:30 pm | Annual General Meeting |
| 07/06/2023 07:00 pm | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -280 -207 -35.39% | -346 -315 -9.84% | -257 -335 23.25% | -269 -320 16.08% | -196 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -286 -213 -34.56% | -357 -325 -9.67% | -273 -346 21.13% | -293 -307 4.58% | -265 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -285 -235 -21.41% | -356 -319 -11.58% | -269 -339 20.4% | -283 -282 -0.53% | -246 |
|
Net income Million USD | Released Forecast Spread | -131 | -285 -203 -40.28% | -356 -319 -11.68% | -269 -325 17.17% | -283 -274 -3.45% | -241 |
|
EPS USD | Released Forecast Spread | -6,67 | -21,9 -7,93 -176.58% | -2,14 -1,88 -13.95% | -1,43 -1,79 20.14% | -1,46 -1,51 3.49% | -1,13 |
| Announcement Date | 10/11/20 | 24/03/21 | 16/03/22 | 16/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -28,1 -91,0 69.15% | -69,1 -95,0 27.26% | -82,2 -99,0 17% | -79,7 -73,0 -9.19% | -112 -78,0 -43.39% | -79,4 -75,8 -4.75% | -51,7 | -43,1 | -38,0 | ||||
|
EBIT Million USD | Released Forecast Spread | -111 -101 -9.85% | -31,7 -95,3 66.76% | -72,9 -98,4 25.89% | -86,2 -101 14.39% | -81,8 -97,9 16.45% | -84,1 -70,7 -18.97% | -116 -85,5 -36.04% | -2,18 -91,7 97.62% | -90,6 -79,7 -13.65% | -68,6 | -65,7 | -65,3 | -65,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -111 -73,0 -51.69% | -31,4 -91,0 65.44% | -72,5 -95,0 23.72% | -85,1 -99,0 14.02% | -80,4 -97,0 17.07% | -82,1 -70,1 -17.15% | -114 -80,1 -42.41% | 0,98 -84,2 101.17% | -88,1 -76,2 -15.63% | -71,1 | -69,1 | -70,0 | -71,2 |
|
Net income Million USD | Released Forecast Spread | -111 -73,0 -51.69% | -31,4 -91,0 65.44% | -72,5 -95,0 23.72% | -85,1 -99,0 14.02% | -80,4 -97,0 17.07% | -82,1 -70,1 -17.15% | -114 -80,1 -42.41% | 0,98 -84,2 101.17% | -88,1 -76,2 -15.63% | -71,1 | -69,1 | -70,0 | -71,2 |
|
EPS USD | Released Forecast Spread | -0,60 -0,39 -52.95% | -0,17 -0,52 67.43% | -0,39 -0,53 26.6% | -0,45 -0,53 15.09% | -0,42 -0,52 18.71% | -0,43 -0,37 -16.22% | -0,59 -0,43 -38.17% | 0,00 -0,45 - | -0,45 -0,38 -18.98% | -0,32 | -0,29 | -0,28 | -0,28 |
| Announcement Date | 16/03/22 | 10/05/22 | 04/08/22 | 02/11/22 | 16/03/23 | 08/05/23 | 03/08/23 | 08/11/23 | 29/02/24 | - | - | - | - |
More events
Past sector events for Sana Biotechnology, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SANA Stock
- Calendar Sana Biotechnology, Inc.
